Followers | 3181 |
Posts | 208744 |
Boards Moderated | 2 |
Alias Born | 02/04/2004 |
Friday, March 16, 2018 10:13:38 AM
The reason the market continues to punish IPCI so badly is 100% due to the fact that Dr. Odidi has not only allowed time to catch up to his ongoing efforts at IPCI...he's allowed time to pass him by while continuing to fumble along at a snails pace instead of finding creative solutions to unlocking some real and relevant potential progress out of PODRAS and their Regabatin and Oxy NDA candidates.
The fact that Dr. Odidi saw fit to launch those new China operations for his Smart Pharma Shanghai company over the past calendar year without even bothering to get in front of it with IPCI shareholders and the IPCI market...only goes to show how completely out of touch with the constant market realities/dynamics in play he is.
It's not how many times IPCI and IPCI shareholders have been kicked in the guts over the past 4 years...it's how IPCI mgmt. reacts to the constant challenges faced that matters. And sadly we continue to see ZERO signs whatsoever that Dr. Odidi and the rest of his mgmt. team are even aware of how to go about exploring creative solutions.
And we certainly aren't seeing any evidence whatsoever that Dr. Odidi's willing to step aside and assume the roles of Founder and Chief Scientific Officer so that a far more seasoned pro CEO can step in b4 it's too late.
In the right CEO's hands PODRAS could still become a global blockbuster in 2 to 3 years time...but all the while Dr. Odidi doesn't see any problems whatsoever in the lack of progress made...the likelihood that PODRAS never realizes any of its inherent potential becomes the eventual probable outcome.
Clearly Dr. Odidi has proven over these past 4 years alone that he can't wear all the hats at IPCI and expect to make IPCI a successful company...but for whatever reason he doesn't want to listen to his shareholders collective voice and make the appropriate and needed changes/adjustments b4 it's too late!
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM